Home » Newsletters » BioWorld

BioWorld

March 22, 2000

View Archived Issues

Live Weakened Rabies Virus Signs On As Vector In Protective, Two-Armed Anti-HIV-1 Vaccine

Aclara's Stock Skyrockets As Its IPO Raises $189 Million

Triangle Spins Out New Firm Focused On Health Information

HGS Receives Phage Display Through $16M Pact With Dyax

Enzon Raises $83M To Develop PEG and SCA Compounds

Other News To Note

Abgenix, Corixa To Battle For Antibody Rights In Auction

Celera Buys Paracel In Stock Swap To Boost Bioinformatics

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026